Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Active Refractory Rheumatoid Arthritis”

14 trials

Showing 14 of 14 results

Large-scale testing (Phase 3)Ended earlyNCT01410695
What this trial is testing

Masitinib in Refractory Active Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis (RA)
AB Science 324
Testing effectiveness (Phase 2)Study completedNCT05460832
What this trial is testing

Phase 2b Study of MBS2320 in Participants With Methotrexate-Refractory RA

Who this might be right for
Rheumatoid Arthritis
Modern Biosciences Ltd 248
Large-scale testing (Phase 3)UnknownNCT06456489
What this trial is testing

Pulse Steroid Injection in Refractory Rheumatoid Arthritis

Who this might be right for
Active Rheumatoid Arthritis
Sohag University 268
Early research (Phase 1)Looking for participantsNCT06946199
What this trial is testing

An Open-label Study of Cizutamig in Refractory Seropositive Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis (RA)
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 28
Testing effectiveness (Phase 2)Looking for participantsNCT06570798
What this trial is testing

Master Protocol Assessing Inebilizumab and Blinatumomab in Autoimmune Diseases

Who this might be right for
Systemic Lupus ErythematosusActive Refractory Rheumatoid Arthritis
Amgen 220
Early research (Phase 1)Ended earlyNCT06087406
What this trial is testing

A Phase 1b Study of Imvotamab in Moderate to Severe Rheumatoid Arthritis

Who this might be right for
Rheumatoid ArthritisArthritis, RheumatoidArthritis
IGM Biosciences, Inc. 33
Very early researchNot Yet RecruitingNCT06982547
What this trial is testing

Clinical Study on the Treatment of Refractory Rheumatoid Arthritis With UTAA91 Injection

Who this might be right for
Rheumatoid Arthritis (RA)
PersonGen BioTherapeutics (Suzhou) Co., Ltd. 24
Testing effectiveness (Phase 2)Looking for participantsNCT07639177
What this trial is testing

Faecal Microbiota Transplantation in Patients With Refractory Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
Peking Union Medical College Hospital 40
Testing effectiveness (Phase 2)Active Not RecruitingNCT06475495
What this trial is testing

Comparison of B-cell Depletion by Rituximab and Anti-CD 19 CAR-T Therapy in Patients With Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
Charite University, Berlin, Germany 13
Testing effectiveness (Phase 2)Study completedNCT01384422
What this trial is testing

Safety and Preliminary Efficacy of GLPG0634 in Methotrexate-refractory Active Rheumatoid Arthritis Patients

Who this might be right for
Rheumatoid Arthritis
Lakefront Biotherapeutics NV 36
Very early researchLooking for participantsNCT07001956
What this trial is testing

The Clinical Study on the Treatment of Refractory RA With UTAA91 Injection

Who this might be right for
Rheumatoid Arthritis (RA)
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 24
Large-scale testing (Phase 3)Study completedNCT01689532
What this trial is testing

CNTO 136 (Sirukumab) Administered Subcutaneously in Japanese Patients With Active Rheumatoid Arthritis Unresponsive to Methotrexate or Sulfasalazine

Who this might be right for
Arthritis, Rheumatoid
Janssen Pharmaceutical K.K. 122
Testing effectiveness (Phase 2)Study completedNCT01211249
What this trial is testing

GLPG0259 in Methotrexate-refractory Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
Lakefront Biotherapeutics NV 30
Testing effectiveness (Phase 2)Study completedNCT01668641
What this trial is testing

Dose-ranging Study With GLPG0634 in Methotrexate-refractory Active Rheumatoid Arthritis Patients

Who this might be right for
Rheumatoid Arthritis
Lakefront Biotherapeutics NV 91

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation